A case of cutaneous leukocytoclastic vasculitis associated with gabapentin

Gabapentin was approved for use in the USA in 1994 as an add-on drug in adults who have partial seizures either alone or with secondary generalised seizures. Its use has been expanded to include treatment for other conditions such as neuropathic pain and paraesthesiae. Gabapentin was prescribed for...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Singapore medical journal 2003, Vol.44 (1), p.42-44
Hauptverfasser: POON, D. Y. H, LAW, N. M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 44
container_issue 1
container_start_page 42
container_title Singapore medical journal
container_volume 44
creator POON, D. Y. H
LAW, N. M
description Gabapentin was approved for use in the USA in 1994 as an add-on drug in adults who have partial seizures either alone or with secondary generalised seizures. Its use has been expanded to include treatment for other conditions such as neuropathic pain and paraesthesiae. Gabapentin was prescribed for our patient who had persistent left-sided hemi-paraesthesiae consequential of a previous thalamic infarct. One week after commencement of gabapentin, she developed an adverse reaction in the form of a purpuric rash over bilateral lower limbs. Skin biopsy revealed histological features of cutaneous leukocytoclastic vasculitis. This rash completely resolved with withdrawal of gabapentin and steroidal treatment. This cutaneous adverse reaction to gabapentin has not been reported in the medical literature.
format Article
fullrecord <record><control><sourceid>pubmed_pasca</sourceid><recordid>TN_cdi_pubmed_primary_12762564</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>12762564</sourcerecordid><originalsourceid>FETCH-LOGICAL-p152t-2433ba38a977b09ca6d8fef70ab71034612a90f336eb882a33b40b9a299b0c343</originalsourceid><addsrcrecordid>eNpFzztPwzAUBWAPIFoKfwF5YYx047fHquJVVWKBubp2bDCkSRQ7oP57IlHEdJZPR-eckSUA15VUWi7IZc4fAEyDMRdkUTOtmFRiSbZr6jEH2kfqp4Jd6KdM2zB99v5Yet9iLsnTL8x-alNJmWLOvU9YQkO_U3mnb-hwCF1J3RU5j9jmcH3KFXm9v3vZPFa754enzXpXDbVkpWKCc4fcoNXagfWoGhND1IBO18CFqhlaiJyr4IxhOGsBziKz1oHngq_IzW_vMLlDaPbDmA44Hvd_p2ZwewLzbGzjiJ1P-d8JBZpJxn8AYgZU_Q</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>A case of cutaneous leukocytoclastic vasculitis associated with gabapentin</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>POON, D. Y. H ; LAW, N. M</creator><creatorcontrib>POON, D. Y. H ; LAW, N. M</creatorcontrib><description>Gabapentin was approved for use in the USA in 1994 as an add-on drug in adults who have partial seizures either alone or with secondary generalised seizures. Its use has been expanded to include treatment for other conditions such as neuropathic pain and paraesthesiae. Gabapentin was prescribed for our patient who had persistent left-sided hemi-paraesthesiae consequential of a previous thalamic infarct. One week after commencement of gabapentin, she developed an adverse reaction in the form of a purpuric rash over bilateral lower limbs. Skin biopsy revealed histological features of cutaneous leukocytoclastic vasculitis. This rash completely resolved with withdrawal of gabapentin and steroidal treatment. This cutaneous adverse reaction to gabapentin has not been reported in the medical literature.</description><identifier>ISSN: 0037-5675</identifier><identifier>PMID: 12762564</identifier><identifier>CODEN: SIMJA3</identifier><language>eng</language><publisher>Singapore: Singapore Medical Association</publisher><subject>Acetates - adverse effects ; Aged ; Amines ; Anticonvulsants - adverse effects ; Biological and medical sciences ; Cyclohexanecarboxylic Acids ; Drug toxicity and drugs side effects treatment ; Female ; Foot ; gamma-Aminobutyric Acid ; Humans ; Medical sciences ; Pharmacology. Drug treatments ; Toxicity: cardiovascular system ; Tropical medicine ; Vasculitis, Leukocytoclastic, Cutaneous - chemically induced</subject><ispartof>Singapore medical journal, 2003, Vol.44 (1), p.42-44</ispartof><rights>2003 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,4010</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=14607252$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12762564$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>POON, D. Y. H</creatorcontrib><creatorcontrib>LAW, N. M</creatorcontrib><title>A case of cutaneous leukocytoclastic vasculitis associated with gabapentin</title><title>Singapore medical journal</title><addtitle>Singapore Med J</addtitle><description>Gabapentin was approved for use in the USA in 1994 as an add-on drug in adults who have partial seizures either alone or with secondary generalised seizures. Its use has been expanded to include treatment for other conditions such as neuropathic pain and paraesthesiae. Gabapentin was prescribed for our patient who had persistent left-sided hemi-paraesthesiae consequential of a previous thalamic infarct. One week after commencement of gabapentin, she developed an adverse reaction in the form of a purpuric rash over bilateral lower limbs. Skin biopsy revealed histological features of cutaneous leukocytoclastic vasculitis. This rash completely resolved with withdrawal of gabapentin and steroidal treatment. This cutaneous adverse reaction to gabapentin has not been reported in the medical literature.</description><subject>Acetates - adverse effects</subject><subject>Aged</subject><subject>Amines</subject><subject>Anticonvulsants - adverse effects</subject><subject>Biological and medical sciences</subject><subject>Cyclohexanecarboxylic Acids</subject><subject>Drug toxicity and drugs side effects treatment</subject><subject>Female</subject><subject>Foot</subject><subject>gamma-Aminobutyric Acid</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Toxicity: cardiovascular system</subject><subject>Tropical medicine</subject><subject>Vasculitis, Leukocytoclastic, Cutaneous - chemically induced</subject><issn>0037-5675</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFzztPwzAUBWAPIFoKfwF5YYx047fHquJVVWKBubp2bDCkSRQ7oP57IlHEdJZPR-eckSUA15VUWi7IZc4fAEyDMRdkUTOtmFRiSbZr6jEH2kfqp4Jd6KdM2zB99v5Yet9iLsnTL8x-alNJmWLOvU9YQkO_U3mnb-hwCF1J3RU5j9jmcH3KFXm9v3vZPFa754enzXpXDbVkpWKCc4fcoNXagfWoGhND1IBO18CFqhlaiJyr4IxhOGsBziKz1oHngq_IzW_vMLlDaPbDmA44Hvd_p2ZwewLzbGzjiJ1P-d8JBZpJxn8AYgZU_Q</recordid><startdate>2003</startdate><enddate>2003</enddate><creator>POON, D. Y. H</creator><creator>LAW, N. M</creator><general>Singapore Medical Association</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>2003</creationdate><title>A case of cutaneous leukocytoclastic vasculitis associated with gabapentin</title><author>POON, D. Y. H ; LAW, N. M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p152t-2433ba38a977b09ca6d8fef70ab71034612a90f336eb882a33b40b9a299b0c343</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Acetates - adverse effects</topic><topic>Aged</topic><topic>Amines</topic><topic>Anticonvulsants - adverse effects</topic><topic>Biological and medical sciences</topic><topic>Cyclohexanecarboxylic Acids</topic><topic>Drug toxicity and drugs side effects treatment</topic><topic>Female</topic><topic>Foot</topic><topic>gamma-Aminobutyric Acid</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Toxicity: cardiovascular system</topic><topic>Tropical medicine</topic><topic>Vasculitis, Leukocytoclastic, Cutaneous - chemically induced</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>POON, D. Y. H</creatorcontrib><creatorcontrib>LAW, N. M</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Singapore medical journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>POON, D. Y. H</au><au>LAW, N. M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A case of cutaneous leukocytoclastic vasculitis associated with gabapentin</atitle><jtitle>Singapore medical journal</jtitle><addtitle>Singapore Med J</addtitle><date>2003</date><risdate>2003</risdate><volume>44</volume><issue>1</issue><spage>42</spage><epage>44</epage><pages>42-44</pages><issn>0037-5675</issn><coden>SIMJA3</coden><abstract>Gabapentin was approved for use in the USA in 1994 as an add-on drug in adults who have partial seizures either alone or with secondary generalised seizures. Its use has been expanded to include treatment for other conditions such as neuropathic pain and paraesthesiae. Gabapentin was prescribed for our patient who had persistent left-sided hemi-paraesthesiae consequential of a previous thalamic infarct. One week after commencement of gabapentin, she developed an adverse reaction in the form of a purpuric rash over bilateral lower limbs. Skin biopsy revealed histological features of cutaneous leukocytoclastic vasculitis. This rash completely resolved with withdrawal of gabapentin and steroidal treatment. This cutaneous adverse reaction to gabapentin has not been reported in the medical literature.</abstract><cop>Singapore</cop><pub>Singapore Medical Association</pub><pmid>12762564</pmid><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0037-5675
ispartof Singapore medical journal, 2003, Vol.44 (1), p.42-44
issn 0037-5675
language eng
recordid cdi_pubmed_primary_12762564
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects Acetates - adverse effects
Aged
Amines
Anticonvulsants - adverse effects
Biological and medical sciences
Cyclohexanecarboxylic Acids
Drug toxicity and drugs side effects treatment
Female
Foot
gamma-Aminobutyric Acid
Humans
Medical sciences
Pharmacology. Drug treatments
Toxicity: cardiovascular system
Tropical medicine
Vasculitis, Leukocytoclastic, Cutaneous - chemically induced
title A case of cutaneous leukocytoclastic vasculitis associated with gabapentin
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-16T07%3A15%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_pasca&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20case%20of%20cutaneous%20leukocytoclastic%20vasculitis%20associated%20with%20gabapentin&rft.jtitle=Singapore%20medical%20journal&rft.au=POON,%20D.%20Y.%20H&rft.date=2003&rft.volume=44&rft.issue=1&rft.spage=42&rft.epage=44&rft.pages=42-44&rft.issn=0037-5675&rft.coden=SIMJA3&rft_id=info:doi/&rft_dat=%3Cpubmed_pasca%3E12762564%3C/pubmed_pasca%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/12762564&rfr_iscdi=true